Dr. Mathias Kroll is a seasoned expert with over 27 years of experience in biopharmaceutical research and business development. Since April 2024, he has served as Chief Business Officer at Cynata Therapeutics Ltd. Throughout his career, Dr. Kroll has led a wide range of global biopharmaceutical transactions and forged numerous high-value partnerships, some worth several billion dollars.